CoreVision Biopharma Closes Nearly RMB 100 Million Angel Round, Pioneering Visualized Theranostic Targeted Radiopharmaceuticals
Dedicated to becoming a trailblazer in China's TRT space.
Dedicated to becoming a trailblazer in China's TRT space.
Evolution never stops, and neither does computation.
On August 9, SenseTime — an AI platform company focused on video intelligent analysis and spatiotemporal data management — completed its fourth funding round of RMB 400 million. This Series C financing marks the deep maturation of its business model and its ascension to the industry's leading ranks. **The round was co-led by Zhangjiang Hi-Tech, Zhangjiang Group, Langtai Capital, and CCTV Integrated Media Fund, with existing shareholders Guochuang Zhongding and Linear Capital continuing to participate.** With sustained backing from investors, SenseTime...
GPs need to buckle down and get the work done — happily.
Walk alongside more outstanding founders.
In the first half of 2022, order value doubled as the company accelerated global expansion and drove R&D innovation.
36Kr has learned that Shanghai Feiyue Cloud Technology Co., Ltd. (hereinafter referred to as "Feiyue Cloud") announced today that it has completed a seed funding round. According to the company, this round raised tens of millions of RMB, led by Linear Capital, with AngelPlus following on.
After two months of recruiting, interviews, and conversations, we're thrilled to announce that the inaugural Linear Fellow cohort has been finalized and is about to begin the next phase!
VBData's "6th Future Healthcare 100 Conference" took "China Story" as its theme. During the heavyweight panel discussion, titled *Investing in Future Healthcare: How to Support the Emergence of World-Class Innovative Companies*, six investment firms gathered to debate how China can continue producing world-class innovators and lead at the global frontier.